Cameron John Reynolds Insider Trading $SNDC VOLITIONRX LTD
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Cameron John Reynolds.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Cameron John Reynolds. Cameron John Reynolds is President and CEO in VOLITIONRX LTD ($SNDC) and C.F.O. in CANYON COPPER CORP. ($CNYC).
Cameron John Reynolds in VOLITIONRX LTD
Trading Symbol: SNDCIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Cameron John Reynolds: President and CEO
Holdings: 1,176,273 shares
Latest Transaction: Jul 23 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Cameron John Reynolds in VOLITIONRX LTD
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 23 2020 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | M | 3.00 | 50,000 | 150,000 | 0 | |
Jul 23 2020 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | M | 2.50 | 50,000 | 125,000 | 0 | |
Jul 23 2020 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Payment of Exercise | F | 3.95 | 43,627 | 172,327 | 1,142,373 | 1.2 M to 1.1 M (-3.68 %) |
Jul 23 2020 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Buy | M | 3.00 | 50,000 | 150,000 | 1,186,000 | 1.1 M to 1.2 M (+4.40 %) |
Jul 23 2020 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Payment of Exercise | F | 3.95 | 40,273 | 159,078 | 1,136,000 | 1.2 M to 1.1 M (-3.42 %) |
Jul 23 2020 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Buy | M | 2.50 | 50,000 | 125,000 | 1,176,273 | 1.1 M to 1.2 M (+4.44 %) |
May 22 2020 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Buy | P | 2.75 | 4,000 | 11,000 | 1,126,273 | 1.1 M to 1.1 M (+0.36 %) |
Apr 15 2020 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | A | 3.60 | 85,000 | 306,000 | 85,000 | |
Dec 06 2019 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Buy | P | 4.24 | 1,100 | 4,664 | 1,122,273 | 1.1 M to 1.1 M (+0.10 %) |
Feb 13 2019 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | A | 3.25 | 50,000 | 162,500 | 50,000 | |
Dec 21 2018 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | A | 4.00 | 55,000 | 220,000 | 55,000 | |
Dec 21 2018 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | D | 4.00 | 55,000 | 220,000 | 0 | |
Dec 21 2018 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | A | 3.00 | 50,000 | 150,000 | 50,000 | |
Dec 21 2018 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | A | 2.50 | 50,000 | 125,000 | 50,000 | |
Dec 21 2018 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | D | 3.00 | 50,000 | 150,000 | 0 | |
Dec 21 2018 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | D | 2.50 | 50,000 | 125,000 | 0 | |
Aug 17 2018 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Buy | P | 1.91 | 6,500 | 12,415 | 1,121,173 | 1.1 M to 1.1 M (+0.58 %) |
Jan 25 2018 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | A | 4.00 | 75,000 | 300,000 | 75,000 | |
Aug 17 2017 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Buy | P | 2.77 | 3,630 | 10,055 | 1,007,718 | 1 M to 1 M (+0.36 %) |
Apr 03 2017 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | A | 5.00 | 100,000 | 500,000 | 100,000 | |
Nov 21 2016 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | M | 3.00 | 20,000 | 60,000 | 0 | |
Nov 21 2016 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Payment of Exercise | F | 4.48 | 13,393 | 60,001 | 1,114,673 | 1.1 M to 1.1 M (-1.19 %) |
Nov 21 2016 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Buy | M | 3.00 | 20,000 | 60,000 | 1,128,066 | 1.1 M to 1.1 M (+1.80 %) |
May 24 2016 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | X | 3.00 | 4,000 | 12,000 | 0 | |
May 24 2016 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | M | 3.00 | 20,000 | 60,000 | 0 | |
May 24 2016 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Sell | S | 3.54 | 3,390 | 12,001 | 28,897 | 32.3 K to 28.9 K (-10.50 %) |
May 24 2016 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Buy | X | 3.00 | 4,000 | 12,000 | 32,287 | 28.3 K to 32.3 K (+14.14 %) |
May 24 2016 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Payment of Exercise | F | 3.54 | 16,950 | 60,003 | 1,108,066 | 1.1 M to 1.1 M (-1.51 %) |
May 24 2016 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Buy | M | 3.00 | 20,000 | 60,000 | 1,125,016 | 1.1 M to 1.1 M (+1.81 %) |
Apr 22 2016 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | X | 2.60 | 1,429 | 3,715 | 0 | |
Apr 22 2016 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | X | 2.60 | 1,172 | 3,047 | 0 | |
Apr 22 2016 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Buy | X | 2.60 | 1,429 | 3,715 | 28,287 | 26.9 K to 28.3 K (+5.32 %) |
Apr 22 2016 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Buy | X | 2.60 | 1,172 | 3,047 | 1,103,844 | 1.1 M to 1.1 M (+0.11 %) |
Apr 19 2016 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | A | 4.00 | 125,000 | 500,000 | 125,000 | |
Sep 15 2015 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | A | 5.00 | 20,000 | 100,000 | 20,000 | |
Sep 15 2015 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | A | 5.00 | 20,000 | 100,000 | 20,000 | |
Sep 15 2015 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | A | 4.00 | 20,000 | 80,000 | 20,000 | |
Sep 15 2015 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | A | 4.00 | 20,000 | 80,000 | 20,000 | |
Sep 15 2015 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | A | 3.00 | 20,000 | 60,000 | 20,000 | |
Sep 15 2015 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | A | 3.00 | 20,000 | 60,000 | 20,000 | |
Sep 15 2015 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | D | 5.00 | 20,000 | 100,000 | 0 | |
Sep 15 2015 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | D | 5.00 | 20,000 | 100,000 | 0 | |
Sep 15 2015 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | D | 4.00 | 20,000 | 80,000 | 0 | |
Sep 15 2015 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | D | 4.00 | 20,000 | 80,000 | 0 | |
Sep 15 2015 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | D | 3.00 | 20,000 | 60,000 | 0 | |
Sep 15 2015 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | D | 3.00 | 20,000 | 60,000 | 0 | |
Sep 15 2015 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | A | 3.00 | 50,000 | 150,000 | 50,000 | |
Sep 15 2015 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | A | 2.50 | 50,000 | 125,000 | 50,000 | |
Jul 27 2015 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Option Exercise | A | 4.00 | 55,000 | 220,000 | 55,000 | |
May 18 2015 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Buy | P | 3.41 | 100 | 341 | 1,103,844 | 1.1 M to 1.1 M (+0.01 %) |
May 18 2015 | SNDC | VOLITIONRX LTD | Reynolds Cameron John | President and CEO | Buy | P | 3.32 | 1,400 | 4,648 | 1,103,744 | 1.1 M to 1.1 M (+0.13 %) |
Page: 1